Open AccessLab studies and early clinical trials suggest that RNAi could become a potent new approach to treating many medical conditions, including autoimmune diseases, cancer, influenza, and more.
Author(s) -
Mike May
Publication year - 2007
Publication title -
biotechniques/biotechniques
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.617
H-Index - 131
eISSN - 1940-9818
pISSN - 0736-6205
DOI - 10.2144/000112431
Subject(s) - rna interference , cancer , clinical trial , autoimmune disease , immunology , computational biology , biology , medicine , virology , bioinformatics , genetics , gene , rna , antibody